Article Information
History
- July 18, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Deshni Jayathilaka1,#,
- Chandima Jeewandara1,#,
- Laksiri Gomes1,
- Tibutius Thanesh Pramanayagam Jayadas1,
- Achala Kamaladasa1,
- Dinuka Guruge2,
- Pradeep Darshana1,
- Thushali Ranasinghe1,
- Inoka Sepali Abyrathna1,
- Saubhagya Danasekara1,
- Buddini Gunathilaka1,
- Heshan Kuruppu1,
- Ananda Wijewickrama3,
- Ruwan Wijayamuni2,
- Lisa Schimanski4,5,
- T.K. Tan3,4,
- Graham S. Ogg5,
- Alain Townsend4,5 and
- Gathsaurie Neelika Malavige1,5,*
- 1Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, University of Sri Jayewardenepura, Nugegoda, Sri Lanka
- 2Colombo Municipal Council, Colombo, Sri Lanka
- 3National Institute of Infectious Disease, Sri Lanka
- 4MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom
- 5Centre for Translational Immunology, Chinese Academy of Medical Sciences Oxford Institute, University of Oxford, Oxford, United Kingdom
- ↵*Correspondence should be addressed to: Prof. Neelika Malavige DPhil (Oxon), FRCP (Lond), FRCPath (UK), Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayawardanapura, Sri Lanka., Tel +94 (0) 772443193; Fax: +94 (0) 112802026, Email: gathsaurie.malavige{at}ndm.ox.ac.uk
↵# Contributed equally
Posted July 18, 2021.
Comparison of kinetics of immune responses to SARS-CoV-2 proteins in individuals with varying severity of infection and following a single dose of the AZD1222
